Daniel Schriber is an experienced professional in impact investment and humanitarian operations, currently serving as the Head of Investments at Symbiotics since January 2006. Under Daniel's leadership, the investment team expanded to 25 members, achieving over USD 1 billion in annual investment origination and a portfolio nearing USD 3 billion with a low default rate. Daniel's previous roles at Symbiotics include Director of Research & Advisory and Regional Manager for EMEA. Prior to Symbiotics, Daniel held various significant positions at the International Committee of the Red Cross, including Deputy Head of Operations for Eastern Europe, and has extensive experience in managing large teams and budgets across different regions. Daniel holds multiple degrees, including a Master’s in International Relations and an Executive MBA in Finance and Management.